Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Acutaas Chemicals is the renamed Ami Organics, a specialty chemicals company focused on advanced pharmaceutical intermediates for chronic-therapy APIs (including intermediates for widely used CNS, anticoagulant and other molecules) and specialty chemicals for agrochemical and fine-chemical applications. It supplies domestic and global pharma customers with a growing CDMO/contract development stream and has been adding capacity in electrolyte additives and semiconductor-adjacent chemistry. Revenue is driven by pharma intermediates volumes and new molecule commercialisation.
A niche leader in select pharma intermediates with high global share in its core molecules.
Acutaas Chemicals Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Acutaas Chemicals Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 3.69 crore to 8.19 crore in FY25, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY25 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 43.51 | 19.81 | 11.67 |
| Book value / share (₹) | 208.96 | 161.24 | 185.13 |
| Return on equity | 20.8% | 12.0% | 6.3% |
| Return on capital employed | 25.4% | 15.3% | 13.9% |
| Operating margin | 33.2% | 20.4% | 15.7% |
| Net margin | 26.6% | 15.9% | 6.8% |
| EBITDA | ₹480 Cr | ₹232 Cr | ₹128 Cr |
| Free cash flow | ₹-36 Cr | ₹-76 Cr | ₹-155 Cr |
| Total debt | ₹26 Cr | ₹8 Cr | ₹217 Cr |
| Debt to equity | 0.02 | 0.01 | 0.32 |
| Interest coverage | 136.0 | 33.0 | 18.9 |
| Current ratio | 3.82 | 3.91 | 1.74 |
| Shares outstanding | 8,18,71,200 | 8,18,69,000 | 3,68,80,600 |
Open the full income statement, balance sheet and cash flow for ACUTAAS →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.